Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 1/20 | 0.49 |
| ▸ | APLNR | P35414 | 1/20 | 0.49 |
| ▸ | GLP1R | P43220 | 9/20 | 0.48 |
| ▸ | SCTR | P47872 | 1/20 | 0.48 |
| ▸ | TFPI | P10646 | 1/20 | 0.47 |
| ▸ | GCGR | P47871 | 1/20 | 0.46 |
| ▸ | PTH1R | Q03431 | 3/20 | 0.46 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30823264 | 0.93 | APLNR (0.50) | C5AR1APLNRGLP1RSCTR | |
| SCHEMBL31139071 | 0.90 | APLNR (0.48) | C5AR1APLNRGLP1RSCTRTFPI | |
| SCHEMBL29965839 | 0.90 | NPY4R (0.46) | C5AR1APLNRGLP1RSCTRIL23R | |
| SCHEMBL31496391 | 0.88 | C5AR1 (0.49) | C5AR1APLNRGLP1RSCTRTFPI | |
| SCHEMBL29962070 | 0.88 | GLP1R (0.52) | C5AR1GLP1RSCTRPTH1R | |
| SCHEMBL29754562 | 0.88 | C5AR1 (0.45) | C5AR1APLNRGLP1RSCTRIL23R | |
| SCHEMBL6710592 | 0.88 | NPY4R (0.51) | C5AR1APLNRGLP1RSCTR | |
| SCHEMBL6710584 | 0.88 | NPY4R (0.51) | C5AR1APLNRGLP1RSCTR | |
| SCHEMBL29964770 | 0.87 | GLP1R (0.50) | C5AR1APLNRGLP1RSCTRTFPI | |
| SCHEMBL31182619 | 0.87 | GLP1R (0.58) | GLP1RSCTRGCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115066254-A | Human anti-inflammatory peptides for inhalation treatment of inflammatory lung diseases | 阿德维塔生命科学有限责任公司 | 2022-09-16 | — | — | CN | disclosed |